Companion Animal Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Companion Animal Drugs Market by Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Feline, Canine, and Equine), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography.

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category: Tag:

Report

Description

Global Companion Animal Drugs Market is estimated to be valued US$ 12 Bn in 2021 and poised to grow at CAGR of 6.3% over 2022-2028 to reach USD 19.81 Bn by 2028 owing to rising human and companion animal by means of adoption across the globe. The Companion Animal Drugs Market report gives a comprehensive outlook on the market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal pharmaceutical market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the companion animal pharmaceutical market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of companion animal drug products. Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals is projected to drive market revenue growth over the forecast period.

Companion Animal Drugs Market

MARKET SUMMARY
-
6.3% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 6.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Companion Animal Drugs Market

  • The report on global Companion Animal Drugs Market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution chanel and geography.
  • Companion Animal Drugs Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)
Dynamics

Companion Animal Drugs Market

Rising Pet companionship to human beings expected to drive the market over the forecast period. Companion animals have been trusted for their companionship to the human throughout the history and keeping the companion animals healthy is a top priority for caregivers everywhere in the world, which is expected to drive the companion animal pharmaceutical market over six years forecast period. Moreover, several studies on human and companion animals’ interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are the primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal drugs over the forecast period.


North-America got significant share

Companion Animal Drugs Market

U.S. market dominated the market with the largest market share in the North America market with moderate growth rate. Europe companion animal drugs market holds a significant share in the global market and projected to grow at a significant growth over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Companion Animal Drugs Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Companion Animal Drugs Market Dynamics
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
    • Regulatory landscape
    • PESTLE analysis
    • Porter’s analysis
  6. Global Companion Animal Drugs Market Analysis, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026
    • Antimicrobials
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Ectoparasiticides
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Endoparacitides
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Endectoparaciticides
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Anti-Inflammatory Drugs
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Anti-Obesity Drugs
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Behavioral Products
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Biologic Drugs
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Analysis, By Animal Type, 2015 – 2019 and Forecast, 2020 – 2026
    • Feline
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Canine
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Equine
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Forecast, By Route of Administration, 2015 – 2019 and Forecast, 2020 – 2026
    • Oral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Parenteral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Topical
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Forecast, By Route of Administration, 2015 – 2019 and Forecast, 2020 – 2026
    • Veterinary Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Veterinary Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Veterinary Clinics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • E-Commerce
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Analysis, By Region, 2015 – 2019 and Forecast, 2020 – 2026
    • North America Companion Animal Drugs Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
      • Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Antimicrobials
        • Ectoparasiticides
        • Endoparacitides
        • Endectoparaciticides
        • Anti-inflammatory Drugs
        • Anti-Obesity Drugs
        • Behavioral Products
        • Biologic Drugs
        • Others
      • Animal Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Feline
        • Canine
        • Equine
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Veterinary Pharmacies
        • Veterinary Hospitals
        • Veterinary Clinics
        • E-Commerce
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Oral
        • Parenteral
        • Topical
        • Others
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • S
    • Canada
  • Europe Companion Animal Drugs Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Drug Therapy
        • Gemcitabine Combination Therapy
        • 5-fluorouracil Combination Therapy
        • Capecitabine Combination Therapy
        • Gemcitabine Alone
      • Radiation Therapy
        • Brachytherapy
        • External Beam Radiation Product (EBRT)
      • Surgery
    • Disease Indication Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Intrahepatic Bile Duct Cancer
    • Extrahepatic Bile Duct Cancer
      • Perihilar Bile Duct Cancer
      • Distal Extrahepatic Bile Duct Cancer
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospitals
      • Pharmacies
      • Oncology Centers
      • Drug Stores
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Germany
    • France
    • K

Report

Company Profile

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Description

Global Companion Animal Drugs Market is estimated to be valued US$ 12 Bn in 2021 and poised to grow at CAGR of 6.3% over 2022-2028 to reach USD 19.81 Bn by 2028 owing to rising human and companion animal by means of adoption across the globe. The Companion Animal Drugs Market report gives a comprehensive outlook on the market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal pharmaceutical market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the companion animal pharmaceutical market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of companion animal drug products. Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals is projected to drive market revenue growth over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX